Better analgesia from pelvic plexus block in prostate biopsy

Better analgesia from pelvic plexus block in prostate biopsy
Compared with periprostatic nerve block, pelvic plexus block, performed under Doppler ultrasound guidance, provides better pain relief for men during office-based transrectal ultrasound-guided prostate biopsy, according to research published in the August issue of The Journal of Urology.

(HealthDay) -- Compared with periprostatic nerve block (PNB), pelvic plexus block (PPB), performed under Doppler ultrasound guidance, provides better pain relief for men during office-based transrectal ultrasound-guided prostate biopsy, according to research published in the August issue of The Journal of Urology.

Francesco Cantiello, M.D., of Magna Graecia University of Catanzaro in Italy, and colleagues conducted a single-center, prospective study involving 180 patients who were randomized to receive intrarectal local anesthesia plus either PPB or PNB prior to undergoing office-based transrectal ultrasound-guided . Local anesthesia consisted of lidocaine 1.5 percent plus nifedipine 0.3 percent cream. PPB consisted of 2.5 mL lidocaine 1 percent plus naropine 0.75 percent injected on each side of the pelvic neurovascular plexus lateral to the seminal vesicle tip. Periprostatic nerve block consisted of the same mixture but was injected on each side of the neurovascular bundles at the prostate-bladder-seminal vesicle. Patients rated the level of pain/discomfort after the procedure.

The researchers found that there was no difference in noted by patients during probe introduction or administration of either the PPB or PNB. However, during the biopsy, pain was statistically significantly lower for patients who received the PPB, and this trend continued until 30 minutes following biopsy completion. No major complications were experienced.

"In conclusion, PPB under guidance provides better analgesia than PNB during office-based transrectal ultrasound-guided prostate biopsy," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola vaccine promising in first human trials

3 hours ago

Researchers say they are one step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

6 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

EU calls for 5,000 doctors to fight Ebola

7 hours ago

The European Commission called for 5,000 doctors to be sent from EU states to combat west Africa's Ebola epidemic, a European source with knowledge of the matter said on Wednesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.